Published in Immunol Rev on January 01, 1982
Complete sequence of an HLA-dR beta chain deduced from a cDNA clone and identification of multiple non-allelic DR beta chain genes. EMBO J (1983) 3.36
Mutations and selection in the generation of class II histocompatibility antigen polymorphism. EMBO J (1984) 2.34
Both alpha and beta chains of HLA-DC class II histocompatibility antigens display extensive polymorphism in their amino-terminal domains. EMBO J (1984) 2.18
Six HLA-D region alpha-chain genes on human chromosome 6: polymorphisms and associations of DC alpha-related sequences with DR types. Proc Natl Acad Sci U S A (1984) 1.90
Exon-intron organization and complete nucleotide sequence of a human major histocompatibility antigen DC beta gene. Proc Natl Acad Sci U S A (1983) 1.85
Genetic mapping of a human class II antigen beta-chain cDNA clone to the SB region of the HLA complex. Proc Natl Acad Sci U S A (1983) 1.78
Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity. J Exp Med (1983) 1.21
Linkage map of three HLA-DR beta-chain genes: evidence for a recent duplication event. Proc Natl Acad Sci U S A (1985) 1.12
Three Ia species with different structures and alloantigenic determinants in an HLA-homozygous cell line. J Exp Med (1983) 1.10
Molecular localization of human class II MT2 and MT3 determinants. J Exp Med (1984) 1.05
Nucleotide sequence of an HLA-DQ alpha chain derived from a DRw9 cell line: genetic and evolutionary implications. Proc Natl Acad Sci U S A (1985) 1.04
Recombination within the HLA-D region. Correlation of molecular genotyping with functional data. J Exp Med (1984) 1.00
Two DR beta allelic series defined by exon II-specific synthetic oligonucleotide genomic hybridization: a method of HLA typing? Proc Natl Acad Sci U S A (1986) 0.92
Differential effects of gamma interferon on expression of HLA class II molecules controlled by the DR and DC loci. Infect Immun (1983) 0.87
A novel HLA-D/DR-like antigen specific for human B lymphoid cells. Biochemical evidence for similarity to but nonidentity with known HLA-D/DR antigens. J Exp Med (1983) 0.79
Primed lymphocyte testing specificity of alloreactive lymphocyte clones for HLA-B locus determinants. Proc Natl Acad Sci U S A (1983) 0.78
The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet (1996) 3.37
HLA-DQ and T-cell receptor genes in insulin-dependent diabetes mellitus. Cold Spring Harb Symp Quant Biol (1986) 3.15
Immunological dissection of human Ia molecules. J Exp Med (1978) 2.93
Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nat Genet (1995) 2.93
The selection of control subjects for case/control analysis of susceptibility to type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1993) 2.63
Human Ia molecules carrying DC1 determinants differ in both alpha- and beta-subunits from Ia molecules carrying DR determinants. Nature (1981) 2.39
Multiple common properties of human beta2-microglobulin and the common portion fragment derived from HL-A antigen molecules. Proc Natl Acad Sci U S A (1973) 2.08
Evidence that celiac disease is primarily associated with a DC locus allelic specificity. Clin Immunol Immunopathol (1983) 2.02
The first large population based twin study of coeliac disease. Gut (2002) 1.91
Subsets of human Ia-like molecules defined by monoclonal antibodies. Mol Immunol (1981) 1.87
Ultrasound biomicroscopic and conventional ultrasonographic study of ocular dimensions in primary angle-closure glaucoma. Ophthalmology (1998) 1.64
IgM and IgG anti-hapten antibody: hemolytic, hemagglutinating and precipitating activity. Proc Soc Exp Biol Med (1965) 1.55
Molecular identification of human Ia antigens coded for by a gene locus closely linked to HLA-DR locus. Immunogenetics (1980) 1.48
Immunoglobulin production in human leukemia cell lines. J Immunol (1966) 1.47
Characterization of soluble substances in plasma carrying HL-A alloantigenic activity and HL-A common antigenic activity. Transplantation (1973) 1.35
Absence of reaction of a xenogenic anti-H-2 serum with mouse embryonal carcinoma cells. Transplantation (1978) 1.29
HL-A antigens from hematopoietic cell lines: molecular size and electrophoretic mobility. J Immunol (1971) 1.28
Radioiodinated soluble HL-A antigens: HL-A alloantigenic characterization and use in radioimmunoassay. J Immunol Methods (1973) 1.26
Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur J Immunol (1995) 1.26
Alloantigens of human lymphoid cell lines; 'human Ia-like antigens'. Alloantigenic activity and cell line, organ and tissue distribution as determined by radioimmunoassay. Immunology (1977) 1.23
Partial amino acid sequence of mouse beta2-microglobulin. Biochem Biophys Res Commun (1976) 1.20
The 11,000-dalton component of mouse H-2. Isolation and identification. Transplantation (1974) 1.19
The component fragments obtained by acid dissociation of papain-solubilized H-2 molecules. J Immunogenet (1976) 1.18
An efficient method for isolation of HL-A antigens from hematopoietic cell lines. J Immunol (1971) 1.18
A mouse plasma substance carrying beta2-microglobulin activity and lacking in H-2 alloantigenic activity. J Immunogenet (1976) 1.17
Choroidal calcification in Bartter syndrome. Am J Ophthalmol (1998) 1.16
The basic structure and the antigenic characteristics of HL-A antigens. Transplant Rev (1974) 1.14
Genome search in celiac disease. Am J Hum Genet (1998) 1.14
Binding of labelled influenza matrix peptide to HLA DR in living B lymphoid cells. Nature (1989) 1.13
Differential tissue distribution and ontogeny of DC-1 and HLA-DR antigens. Immunogenetics (1984) 1.12
Binding of one monoclonal antibody to human Ia molecules can be enhanced by a second monoclonal antibody. Eur J Immunol (1981) 1.11
Absence of a serologically detectable association of murine beta2-microglobulin with the embryonic F9 antigen. Transplantation (1976) 1.11
Human Ia-like antigens in non-lymphoid organs. Immunology (1979) 1.10
Three Ia species with different structures and alloantigenic determinants in an HLA-homozygous cell line. J Exp Med (1983) 1.10
Differences in the expression and release of DR, BR, and DQ molecules in human cells treated with recombinant interferon gamma: comparison to other interferons. Hum Immunol (1985) 1.09
Common antigenic structures of HL-A antigens. VI. Common antigenic determinants located on the 33,000 Dalton alloantigenic fragment portion of papain-solubilized HL-A molecules. Immunology (1975) 1.07
Common antigen structures of HL-A antigens. I. Antigenic determinants recognizable by rabbits on papain-solubilized HL-A molecular fragments. Immunology (1973) 1.06
A radioimmunoassay typing study of non-DQw2-associated celiac disease. Clin Immunol Immunopathol (1986) 1.06
Common antigenic structures of HL-A antigens. II. Small fragments derived from papain-solubilized HL-A antigen molecules. Immunology (1974) 1.05
Human transplantation antigens: isolation and radioimmunoassay. Proc Soc Exp Biol Med (1971) 1.05
Application of the paired label radioantibody technique to tissue sections and cell smears. J Immunol (1967) 1.04
Common antigenic structures of HL-A antigens. IV. HL-A common portion fragment isolated from spent culture medium of human lymphoid cell lines. Immunology (1974) 1.03
Presence of two different immunoglobulin heavy chains in individual cells of established human hematopoietic cell lines. J Immunol (1968) 1.01
Ultrasound biomicroscopy and corneal endothelium in Nd:YAG-laser iridotomy. Ophthalmic Surg Lasers (1996) 1.00
Existence of a genetic risk factor on chromosome 5q in Italian coeliac disease families. Ann Hum Genet (2001) 0.99
Gas tamponade and cyclocryotherapy of a chronic cyclodialysis cleft. Br J Ophthalmol (2009) 0.98
Spreading of HIV-specific CD8+ T-cell repertoire in long-term nonprogressors and its role in the control of viral load and disease activity. Hum Immunol (2001) 0.98
Determination of HL-A zygosity by radioimmunoassay. Transplantation (1972) 0.98
Mechanism of excretion of a bacterial proteinase: factors controlling accumulation of the extracellular proteinase of a Sarcina strain (Coccus P). J Bacteriol (1971) 0.97
Human cell membrane components bound to beta2-microglobulin in T cell-type cell lines. J Immunol (1978) 0.97
Amino acid composition and physicochemical properties of mouse beta2-microglobulin. Biochem Biophys Res Commun (1975) 0.97
HLA-DR typing by radioimmunoassay. Transplantation (1980) 0.96
Common antigenic structures of HL-A antigens. V. An antigenic determinant characteristic of a 33,000-dalton fragment of HL-A molecules. Transplantation (1974) 0.94
Assessment of the specificity of human Ia alloantisera and alloantigens by the use of radioiodinated human Ia antigens. Tissue Antigens (1982) 0.93
HLA-A2-binding peptides cross-react not only within the A2 subgroup but also with other HLA-A-locus allelic products. Hum Immunol (1994) 0.93
A cross-reaction between beta2-microglobulin and kappa-light chains. J Immunol (1977) 0.93
Identification by denaturing high-performance liquid chromatography of numerous polymorphisms in a candidate region for multiple sclerosis susceptibility. Genomics (1999) 0.92
The distribution of DR5, MT2, and MB3 specificities on human Ia subsets. Immunogenetics (1983) 0.92
A micro-immune adherence test for the detction of HL-A antigens. J Immunol (1971) 0.91
Biochemical analysis of a 40,000 mol. wt mouse serum protein which binds beta 2-microglobulin and has serological cross-reactivity with H-2 antigens. Mol Immunol (1982) 0.91
"Silent" alleles at the HLA-C locus. J Immunol (1978) 0.91
Studies of rabbit allotypes by cross-linked antisera. Contemp Top Mol Immunol (1973) 0.90
Detection of complex alleles by direct analysis of DNA heteroduplexes. Immunogenetics (1991) 0.90
Antibodies against human leukemia cell lines. J Immunol (1967) 0.90
Human cell membrane components dominant in T cell lineage: identification and characterization of human TL-like antigens. J Immunol (1979) 0.90
The peptide binding specificity of HLA-B27 subtypes. Immunogenetics (1994) 0.89
Carcinogen-binding antigens in rat liver microsomes. Cancer Res (1966) 0.88
[Methods for optimized cultivation of hair cells from C3H mice]. Nihon Hifuka Gakkai Zasshi (1989) 0.88
Isolation of HL-A 33,000-dalton fragments carrying high HL-A alloantigenic activity. Transplantation (1975) 0.87
Differential effects of gamma interferon on expression of HLA class II molecules controlled by the DR and DC loci. Infect Immun (1983) 0.87
Partial amino acid sequences of the heavy chains of human HLS histocompatibility antigens. Biochem Biophys Res Commun (1976) 0.87
Strong genetic association between HLA-DR3 and a polymorphic variation in the regulatory region of the HSP70-1 gene. Immunogenetics (1993) 0.87
Basic structure of mouse histocompatibility antigens. Transplant Proc (1975) 0.87
Italian population yields world's largest twin registry. Nat Med (1997) 0.87
A safe blood transfusion procedure for immunization against major histocompatibility complex determinants in man. Transplantation (1978) 0.86
Two brc-abl junction peptides bind HLA-A3 molecules and allow specific induction of human cytotoxic T lymphocytes. Leukemia (1996) 0.86
Presentation of peptides by cultured monocytes or activated T cells allows specific priming of human cytotoxic T lymphocytes in vitro. Int Immunol (1995) 0.85
Common antigenic structures of HL-A antigens. 3. An HL-A common antigenic marker closely associated with HL-A alloantigenic activity and detected by use of rabbit anti-rhesus monkey cell membrane antibodies. Immunology (1974) 0.85
Determination of human histocompatibility antigens in the peripheral blood by radioimmunoassay. Transplantation (1972) 0.85
Purification and separation of subsets of human Ia molecules by papain digestion. Immunology (1980) 0.84
Distribution of antigenic determinants recognized by three monoclonal antibodies (Q2/70, Q5/6 and Q5/13) on human Ia-like alloantigens and on their subunits. Immunogenetics (1981) 0.84
Correlations between polymorphisms at the DNA and at the protein level of DRw52 haplotypes, revealed with a variety of techniques. Hum Immunol (1988) 0.83
A new approach to HLA-DPB1 typing combining DNA heteroduplex analysis with allele-specific amplification and enzyme restriction. Immunogenetics (1992) 0.83
Association of responsiveness to the major pollen allergen of Parietaria officinalis with HLA-DRB1* alleles: a multicenter study. Hum Immunol (1996) 0.82
Subgrouping of DR4 alleles by DNA heteroduplex analysis. Hum Immunol (1992) 0.82
A human thy-1-like antigen expressed on cultured leukemic T-cells. Immunogenetics (1982) 0.82